Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT04603001
Title	Study of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 Mutations
Recruitment	Active, not recruiting
Gender	both
Phase	Phase I
Variant Requirements	Yes
Sponsors	Loxo Oncology, Inc.
Indications	hematologic cancer
Therapies	LY3410738
Age Groups:	senior \| adult
Covered Countries	USA \| ISR \| FRA \| FIN \| ESP \| DEU \| CAN \| BEL \| AUS